A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p
Authors
Keywords
Thiosemicarbazone derivatives, Breast cancer, Apoptosis, miRNAs
Journal
Genes & Genomics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-20
DOI
10.1007/s13258-019-00866-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes
- (2018) Franco Bisceglie et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
- (2017) Dong Yang et al. Scientific Reports
- miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1
- (2015) Zhiguo Tong et al. BIOMEDICINE & PHARMACOTHERAPY
- The p53 control of apoptosis and proliferation: lessons from Drosophila
- (2014) Bertrand Mollereau et al. APOPTOSIS
- ATM–p53 pathway causes G2/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells
- (2014) Guodong Yao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- MicroRNA profile in very young women with breast cancer
- (2014) Maria Peña-Chilet et al. BMC CANCER
- Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines
- (2014) Fábio Vandresen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate
- (2013) Ján Eliaš et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study
- (2013) C A Purdie et al. BRITISH JOURNAL OF CANCER
- Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006
- (2013) Mothaffar F. Rimawi et al. JOURNAL OF CLINICAL ONCOLOGY
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- Role of microRNAs in the immune system, inflammation and cancer
- (2013) Jennifer Raisch WORLD JOURNAL OF GASTROENTEROLOGY
- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- Adjuvant treatments for triple-negative breast cancers
- (2012) H. Joensuu et al. ANNALS OF ONCOLOGY
- miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
- (2012) Dan-Xia Zhu et al. CARCINOGENESIS
- Adjuvant systemic treatment for individual patients with triple negative breast cancer
- (2011) Catherine Oakman et al. BREAST
- miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells
- (2011) Shaun Willimott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
- (2011) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of cytotoxic and pro-apoptotic compounds against leukemia cells: Tert-butyl-4-[(3-nitrophenoxy) methyl]-2,2-dimethyloxazolidine-3-carboxylate
- (2011) Mauro C.X. Pinto et al. LIFE SCIENCES
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Molecular biology of Bax and Bak activation and action
- (2010) Dana Westphal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triple-negative breast cancer: Present challenges and new perspectives
- (2010) Franca Podo et al. Molecular Oncology
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- microRNA-205 Regulates HER3 in Human Breast Cancer
- (2009) M. V. Iorio et al. CANCER RESEARCH
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2009) Guo-Qing Chen et al. MEDICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started